Cargando…
Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU;...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837627/ https://www.ncbi.nlm.nih.gov/pubmed/27095564 http://dx.doi.org/10.1186/s12933-016-0385-6 |
_version_ | 1782427887669870592 |
---|---|
author | Östlund Papadogeorgos, Nikolaos Jörneskog, Gun Bengtsson, Mattias Kahan, Thomas Kalani, Majid |
author_facet | Östlund Papadogeorgos, Nikolaos Jörneskog, Gun Bengtsson, Mattias Kahan, Thomas Kalani, Majid |
author_sort | Östlund Papadogeorgos, Nikolaos |
collection | PubMed |
description | BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU; perfusion unit, median (interquartile range)] measuring resting LDF and peak LDF following a six min heating of the skin to 44 °C at the foot, respectively. All patients with ACS and without previously known diabetes underwent oral glucose tolerance test. Thirty-nine patients with type 2 diabetes mellitus free from coronary artery disease served as controls. RESULTS: Peak LDF was significantly (P = 0.03) lower in patients with ACS and diabetes (n = 22; 72 (52)) and diabetes without coronary artery disease (n = 39; 69 (51)) as compared to patients with ACS without diabetes (n = 46; 97 (60)), and patients without ACS (n = 15; 140 (121)), respectively. Patients with ACS (n = 68) had significantly (P = 0.04) lower peak LDF (92 (49)) as compared to patients without ACS (n = 15) (140 (121)). CONCLUSION: Microvascular reactivity is severely impaired in patients with diabetes and ACS. Diabetes has a major influence on microvascular function in patients with coronary artery disease. |
format | Online Article Text |
id | pubmed-4837627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48376272016-04-21 Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome Östlund Papadogeorgos, Nikolaos Jörneskog, Gun Bengtsson, Mattias Kahan, Thomas Kalani, Majid Cardiovasc Diabetol Original Investigation BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU; perfusion unit, median (interquartile range)] measuring resting LDF and peak LDF following a six min heating of the skin to 44 °C at the foot, respectively. All patients with ACS and without previously known diabetes underwent oral glucose tolerance test. Thirty-nine patients with type 2 diabetes mellitus free from coronary artery disease served as controls. RESULTS: Peak LDF was significantly (P = 0.03) lower in patients with ACS and diabetes (n = 22; 72 (52)) and diabetes without coronary artery disease (n = 39; 69 (51)) as compared to patients with ACS without diabetes (n = 46; 97 (60)), and patients without ACS (n = 15; 140 (121)), respectively. Patients with ACS (n = 68) had significantly (P = 0.04) lower peak LDF (92 (49)) as compared to patients without ACS (n = 15) (140 (121)). CONCLUSION: Microvascular reactivity is severely impaired in patients with diabetes and ACS. Diabetes has a major influence on microvascular function in patients with coronary artery disease. BioMed Central 2016-04-20 /pmc/articles/PMC4837627/ /pubmed/27095564 http://dx.doi.org/10.1186/s12933-016-0385-6 Text en © Östlund Papadogeorgos et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Östlund Papadogeorgos, Nikolaos Jörneskog, Gun Bengtsson, Mattias Kahan, Thomas Kalani, Majid Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title | Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title_full | Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title_fullStr | Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title_full_unstemmed | Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title_short | Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
title_sort | severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837627/ https://www.ncbi.nlm.nih.gov/pubmed/27095564 http://dx.doi.org/10.1186/s12933-016-0385-6 |
work_keys_str_mv | AT ostlundpapadogeorgosnikolaos severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome AT jorneskoggun severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome AT bengtssonmattias severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome AT kahanthomas severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome AT kalanimajid severelyimpairedmicrovascularreactivityindiabeticpatientswithanacutecoronarysyndrome |